Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-05Clinical Trial Update: Therapeutic Strategies During Exposure to Pain in an Experimental Design [NA]
Completed clinical trial evaluating therapeutic strategies during exposure to pain in an experimental design. No specific drug information i…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Improving Opioid Safety in Veterans Using Collaborative Care and Decision Support [Phase 1]
A Phase 1 clinical trial at the San Francisco VA Medical Center evaluated collaborative care and decision support to improve opioid safety f…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Ketamine as Adjunctive Analgesic With Bupivacaine in Paravertebral Analgesia for Breast Cancer Surgery [Phase 1, Phase 2]
Phase 1/2 trial evaluating ketamine as an adjunct to bupivacaine for paravertebral analgesia in breast cancer surgery; the study has complet…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Effects of Testosterone Replacement on Pain Sensitivity and Pain Perception [Phase 2]
Phase 2 trial results examining whether testosterone replacement alters pain sensitivity and pain perception in men with hypogonadism.
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: A Safety Study to Investigate the Skin Sensitization Potential of MFC51123 [Phase 1]
A completed Phase 1 safety study evaluated the skin sensitization potential of the compound MFC51123.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-06-28Clinical Trial Update: Detecting Malingering Detection Using Eye Movements and Response Time (MDER) [NA]
A clinical trial from Loewenstein Hospital exploring detection of malingering through eye movements and response time in people with traumat…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Safety and Efficacy Study of Fentanyl Buccal Tablet Use in the Emergency Department for Isolated Extremity Injury [Phase 3]
This update reports on the safety and efficacy results of a Phase 3 trial evaluating fentanyl buccal tablet for acute pain in ED patients wi…
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: The ACTIVE Intervention to Improve Hospice Care [NA]
Clinical trial update for the ACTIVE Intervention aimed at improving hospice care; study completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Testosterone Replacement for Male Opioid Agonist Maintained Patients [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating testosterone replacement in men on opioid agonist therapy with chronic pain and symptomatic hypogonadism; r…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Treating Comorbid Depression During Care Transitions Using Relational Agents [NA]
A completed clinical trial evaluated using relational agents to treat comorbid depression during care transitions in patients with chronic i…
-
CLINICAL_TRIALS research · 2017-06-01Clinical Trial Update: Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management
An observational study sponsored by Proove Bioscience evaluating how genetic testing influences decision-making and care in interventional p…
-
CLINICAL_TRIALS research · 2017-05-31Clinical Trial Update: Osteopathy, Mindfulness and Acceptance-based Programme for Patients With Persistent Pain
This entry documents the completion of a trial evaluating an Osteopathy, Mindfulness and Acceptance-based Programme for patients with persis…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Combined Medication for Improved Analgesia in Superficial Pain [Phase 3]
A Phase 3 trial evaluating a combined medication for improved analgesia in superficial pain has completed and posted its results.
-
FDA approval · 2017-05-26FDA Approved: BELBUCA — Supplemental Application (BioDelivery Sciences International Inc)
The FDA has approved a supplemental application for BELBUCA (buprenorphine hydrochloride buccal film) submitted by BioDelivery Sciences Inte…
-
FDA approval · 2017-05-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for methadone hydrochloride submitted by VistaPharm, LLC. The action represents an additional regula…
-
FDA approval · 2017-05-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Ascend Laboratories, LLC)
FDA approves a supplemental application for methadone hydrochloride (generic) from Ascend Laboratories, LLC.
-
FDA approval · 2017-05-26FDA Approved: MORPHINE SULFATE EXTENDED RELEASE — Supplemental Application (Rhodes Pharmaceuticals L. P.)
The FDA approved a supplemental application for Morphine Sulfate Extended Release from Rhodes Pharmaceuticals L. P., authorizing continued m…
-
FDA approval · 2017-05-26FDA Approved: MORPHINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Morphine Sulfate from Actavis Pharma, Inc., permitting continued marketing of the generic produc…
-
FDA approval · 2017-05-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for methadone hydrochloride from Epic Pharma, LLC, approving the generic formulation.
-
FDA approval · 2017-05-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Methadone Hydrochloride by Hikma Pharmaceuticals USA Inc., updating the product's approved i…
-
FDA approval · 2017-05-26FDA Approved: MORPHINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Morphine Sulfate submitted by Actavis Pharma, Inc.
-
FDA approval · 2017-05-26FDA Approved: XTAMPZA ER — Supplemental Application (Collegium Pharmaceutical, Inc.)
FDA approved a supplemental application for XTAMPZA ER (oxycodone) from Collegium Pharmaceutical, Inc. The approval authorizes changes under…
-
FDA approval · 2017-05-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc., documenting the acceptance of a sup…
-
FDA approval · 2017-05-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc. to modify/update the product's appro…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Web-based Cognitive-behavior Therapy (CBT) for Opioid-treated, Chronic Pain Patients With Aberrant Behavior [NA]
Completed clinical trial evaluating a web-based cognitive-behavior therapy program for opioid-treated chronic pain patients with aberrant be…